GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BATM Advanced Communications Ltd (OTCPK:BVCLF) » Definitions » Cyclically Adjusted Price-to-FCF

BATM Advanced Communications (BATM Advanced Communications) Cyclically Adjusted Price-to-FCF : (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is BATM Advanced Communications Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


BATM Advanced Communications Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for BATM Advanced Communications's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BATM Advanced Communications Cyclically Adjusted Price-to-FCF Chart

BATM Advanced Communications Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BATM Advanced Communications Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BATM Advanced Communications's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BATM Advanced Communications's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BATM Advanced Communications's Cyclically Adjusted Price-to-FCF falls into.



BATM Advanced Communications Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

BATM Advanced Communications's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, BATM Advanced Communications's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0/129.4194*129.4194
=0.000

Current CPI (Dec23) = 129.4194.

BATM Advanced Communications Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -0.018 99.070 -0.024
201512 -0.015 99.792 -0.019
201612 -0.013 101.863 -0.017
201712 -0.010 104.011 -0.012
201812 -0.002 105.998 -0.002
201912 0.012 108.420 0.014
202012 0.033 109.897 0.039
202112 0.005 117.630 0.006
202212 -0.016 125.222 -0.017
202312 0.000 129.419 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BATM Advanced Communications  (OTCPK:BVCLF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


BATM Advanced Communications Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of BATM Advanced Communications's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


BATM Advanced Communications (BATM Advanced Communications) Business Description

Traded in Other Exchanges
Address
4 Ha’harash Street, P.O.B. 7318, Nave Ne'eman Industrial Area, Hod Hasharon, ISR, 4524075
BATM Advanced Communications Ltd is an Israel-based technology company. The company organizes its business operations into two divisions: Networking & Cyber Division and Biomedical Division. Networking and Cyber Division mostly includes the research and development, production, and marketing of data communication products in the field of local and wide area networks and premises management systems. Bio-Medical Division is engaged in the research and development, production, marketing, and distribution of medical products, primarily laboratory diagnostic equipment and sterilization equipment. The majority of its revenue is derived from Biomedical Division. Its geographical segments are the United States of America, Israel, and Europe.